Investing in innovative medicines and vaccines doesn’t just save lives - it transforms our future. It strengthens health, drives economic growth, and improves health security. #AlwaysInnovating

Since the 1990’s, over 70% of life-expectancy gains in developing and high-income countries are tied to pharmaceutical innovation. Today, there are over 12,000 medicines in clinical development, which could expand healthspan and improve the lives of millions. #AlwaysInnovating

🔬 In the margins of the #OECDMinisterial, we organised an event on "Securing Innovation Leadership in Life Sciences: Industrial Policy for Competitiveness, Competition & Health Sovereignty" - a @G7 France labelled event. Speakers including @francediplo's Cyrille Pierre, @sanofi's @DerveloyA, @UnitedHealthGrp's Olga Mironenko Stampfer, @DGEntreprises' Michel Rao, @IFPMA's @DavidReddyIFPMA, @JNJNews' Leonie Volker & more call on the #OECD to: 🪜 Place health as an important pillar for competitive economies 💪 Strengthen innovation for health resilience ✍️ Steer towards pro-growth action through long-term investment

In the last twenty years nearly 1,000 new medicines launched, leading to longer, healthier lives, and bolstering the workforce and economy. Today we have 12,700 medicines in clinical development, which could expand healthspan and improve the lives of millions. #AlwaysInnovating

In the past 10 years, almost 400 cancer treatments have been approved, revolutionizing cancer care, extending and improving lives. Allowing people to spend more time with their families, friends, and communities. ifpma.info/3Qzfluk #AlwaysInnovating

Pharmaceutical innovation transforms health. Medicines and vaccines drive over 70% of life-expectancy gains worldwide. Between 350- 400 new medicines are expected by 2030, helping to prevent, manage, and cure disease. ifpma.info/3Qzfluk #AlwaysInnovating

The pharmaceutical industry is a hi-tech sector where investment creates a multiplier effect on the economy, across R&D intensive industries, scientific discovery, and in creating jobs of the future. ifpma.info/3Qzfluk #AlwaysInnovating

Investing in proven preventative and early interventions could generate $12.5 trillion in economic value annually by 2050 (roughly 7% of global GDP) and deliver an estimated fourfold return. ifpma.info/3Qzfluk #AlwaysInnovating

The pharmaceutical industry is a catalyst for growth, with every dollar generated doubling in value across the global supply chain. ifpma.info/3Qzfluk #AlwaysInnovating

The pharmaceutical industry contributes over $2.3 trillion to global GDP and employs 7.8 million people worldwide, with over 1 million dedicated to R&D. It reinvests nearly 30% of its revenue back into R&D, which is substantially more than most industries. #AlwaysInnovating

The pharmaceutical sector’s R&D activities add $227 billion to global GDP, 30% of its direct contribution to the world economy. The sector’s R&D activities also employ over 1 million highly trained researchers, fostering high-skilled employment and growth. #AlwaysInnovating

Global Health Progress is an interactive resource hub spotlighting collaborations between the innovative pharmaceutical industry and global partners to advance the #SDGs. 🌎 See the numbers behind the impact: globalhealthprogress.org

A nation’s greatest asset is its people’s health. Adult immunization programs can return up to 19 times their initial investment by reducing respiratory infections, limiting complications of chronic diseases, keeping people working, and boosting productivity. #AlwaysInnovating

On the sidelines of the 79th World Health Assembly (#WHA79), IFPMA is hosting several side events. Join us to explore how innovation can shape a healthier, more resilient future for all. 🔗 Register for our side events: ifpma.info/3wfoHBE